Exploring the pharmacological mechanisms of Shuanghuanglian against T-cell acute lymphoblastic leukaemia through network pharmacology combined with molecular docking and experimental validation

Author:

Yang You1ORCID,Yang Yan1,Shen Yunfu2,Liu Jing1,Zeng Yan1,Wei Chengming2,Liu Chunyan1ORCID,Pan Yansha1,Guo Qulian1,Zhong Fangfang1,Guo Ling1,Liu Wenjun1

Affiliation:

1. Department of Pediatrics (Children Hematological Oncology), Birth Defects and Childhood Hematological Oncology Laboratory, The Affiliated Hospital of Southwest Medical University, Sichuan Clinical Research Center for Birth Defects, Luzhou, Sichuan, China

2. State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, China

Funder

the Doctoral Research Initiation Fund of the Affiliated Hospital of Southwest Medical University

Medical Science and Technology Project of Health Commission of Sichuan Province

Sichuan Science and Technology Program

the Special Project of Science and Technology Research of Sichuan Administration of Traditional Chinese Medicine

the Applied Basic Research Project of Southwest Medical University

Science and Technology Strategic Cooperation Project of Luzhou Municipal People’s Government-Southwest Medical University-Applied Basic Research Project

the Natural Science Foundation of Sichuan Province

Publisher

Informa UK Limited

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3